 BEIJING--BUSINESS WIRE--Genetron Holdings Limited Genetron Health or the Company Nasdaq: GTH, a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it will release thirteen new research findings at the 21st World Conference on Lung Cancer WCLC, which will be held virtually from January 28 to 31. One of the research findings Study 3713 was sele 